new brain-dedicated PET system
innovative brain-dedicated PET system
dedicated PET systems
clinical validation
Phase
clinical use
validation of clinical performance
healthcare system
whole-body PET systems
Clinical research
new brain-dedicated Positron Emission Tomography
causes of cognitive decline ONCOVISION
early detection of AD
early diagnosis of Alzheimer’s disease
new diagnostic medical device
times lower
detection of amyloid
β-amyloid biomarker
β biomarker
validation of biomarkers
times higher sensibility
diagnostic medical devices
higher resolution
present business innovation project
business opportunity
commercialisation of organ
growth of ONCOVISION
Mental Disorder Units
lower radiotracer dose
Nuclear Medicine Units of hospitals
development
Europe
Spanish SME
smaller hospital facilities
competitive price
FDA
Japan
patient
USA
design
production
overall objectives
EMEA
Florbetapir
Florbetaben
profitability
company
Proposal number
lesser cost
Flutemetamol
advantages
F-labelled tracers
economic viability
improved characteristics
market
PHC
H2020-SMEINST
feasibility study
Cut-off date
Topic